Table 1.
Neuroprotective effects of resveratrol, curcumin, and ginsenoside on PD
Agent | Mechanism | In vivo/In vitro model | Protection | References |
---|---|---|---|---|
Resveratrol | Anti-Inflammation | N9 microglial cell | Decrease the mRNA levels of IL-1α and TNF-α; Decrease the levels of COX-2 expression; Decrease the levels of NO, TNF-α, IL-1β, IL-6, MCP-1; Suppress production of IL-12p40, IL-23 and C-reactive protein, and respective receptors; Down-regulate MPO; Modulate the activity of PGC-1α, Akt and NF-κB | [10,18-21] |
6-OHDA-induced rat | ||||
MPTP-induced mice | ||||
Primary microglia and astrocytes | ||||
Primary mouse astrocytes | ||||
BV2 microglial cells | ||||
Anti-Apoptosis | PC12 cells | Reduce the activity of caspase-3 and the level of Bax; regulate DNA fragmentation and the mRNA levels and protein expression of Bax, Bcl-2, cleaved caspase-3, and cleaved PARP-1; Activate sirtuin deacetylases and PPAR-γ | [12,24,25,27] | |
SH-SY5Y cells | ||||
HtrA2 knockout mice | ||||
Saccharomyces cerevisiae | ||||
Antioxidation | PC12 cells | Diminish superoxide anion; Inhibit ROS generation; Up-regulate the antioxidant status and the expression of MsrA; Activate PPAR-γ, AMPK, SIRT1; Raise the mRNA expression of PGC-1α’s target genes, | [12,37,38,41] | |
SKN-MC cells | ||||
6-OHDA-induced rat | ||||
SH-SY5Y cells | ||||
Primary fibroblast from PD patients with Park2 mutation Transgenic mice overexpressing PGC-1α DA SN4741 cells | ||||
neurotrophic effect | Primary rat midbrain neuron-glia cultures | Increase neurotrophic factors release in the concentration- and time-dependent manners | [11] | |
Curcumin | Anti-Inflammation | MES23.5 cells | Inhibit NF-κB translocation and AP-1 activation; Inhibit the protein expression of GFAP and iNOS, decrease activation of astrocytes and microglia, reduce pro-inflammatory cytokine, alleviate loss of TH-IR fibers, protect axon | [48-52] |
Primary rat mesencephalic neuron-glia cultures | ||||
MPTP-induced mice | ||||
Anti-Apoptosis | PC12 cells | Reduce MMP loss, attenuate MPP(+)-induced an increase in intracellular ROS level, induce overexpression of BCl-2 and antagonize MPP+-induced overexpression of iNOS; Ease alphaS-induced toxicity; Protect DA neuron axon; Decrease the Bax/Bcl-2 ratio; Reduce the accumulation of A53Tα-synuclein; inhibit the JUN/c-Jun pathway; Block MPP(+) | [53-55,65] | |
MPTP-induced mice | ||||
SH-SY5Y cells | ||||
Ts-1-infected mice | ||||
A53T α-synuclein cell model | ||||
DA neurons in Mpp(+) model | ||||
Antioxidation | MES23.5 cells | Restore MMP, increase level of Cu-Zn superoxide dismutase, suppress ROS; Sustain SOD1 level; reduce the levels of p-p38, cleaved caspase-3 and quinoprotein formation; restore depletion of GSH levels, free radical scaveng; Inhibit oxidative stress and the mitochondrial cell death pathway; activate the Nrf2/ARE pathway; Reduce p53 phosphorylation | [48,51,57,62,64,66-68] | |
6-OHDA-induced mice | ||||
SH-SY5Y cells | ||||
6-OHDA-induced rats | ||||
A53T α-synuclein cell model | ||||
Prevent α-synuclein aggregation and fibrillation | SH-SY5Y cells | Prevent α-synuclein aggregation and fibrillation; Destabilize preformed falphaS; Specifically binds to oligomeric intermediates | [60,71-74] | |
Inhibit MAO-B | MPTP-induced mice | Inhibit MAO-B activity | [71,76] | |
Ginsenoside | Anti-Inflammation | BV2 microglial cells | Suppress NO production and TNF-α secretion, inhibit the mRNA expressions of iNOS, TNF-α, IL-1β, COX-2 and MMP-9, inhibited the phophorylations of PI3K/Akt and MAPKs and the DNA binding activities of NF-kB and AP-1; Suppress phosphorylation and nuclear translocation of NF-κB/p65, phosphorylation and degradation of IκB and the phosphorylation of IKK; inhibit the activation of Akt and ERK1/2; Reduce NO-formation and PGE2 synthesis; attenuate up-regulation TNF-α, IL-1β and IL-6 mRNA, and iNOS and COX-2 expression | [5,84-86] |
Rat primary microglia | ||||
Mesencephalic primary cultures | ||||
PC12 cells | ||||
LPS-treated mice | ||||
Anti-Apoptosis | PC12 cells | Inhibit the activation of caspase-3, reduce iNOS and NO production; Increased the phosphorylation inhibition of Bad through activation of the PI3K/Akt pathway; Enhance the expression of Bcl-2 protein and mRNA, reduce the expression of Bax, Bax mRNA, and iNOS, and attenuate the cleavage of caspase-3 | [87-91] | |
Primary cultured nigral neurons | ||||
MPTP-induced mice | ||||
Antioxidation | PC12 cells | Reduce the generation of ROS and cytochrome c release, restore MMP, increased the phosphorylation inhibition of Bad through activation of the PI3K/Akt pathway; Decrease iron influx, inhibit IRPs; decrease DMT1-mediated ferrous iron uptake and iron-induced cell damage | [87,88,90,91] | |
MES23.5 cells | ||||
Primary cultured nigral neurons | ||||
Neurotrophin-like effects | PC12 cells | Increase neurite outgrowth; Reversed MPTP-induced cell death | [92] | |
SN-K-SH cells |